Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM) has announced the granting of inducement awards to 60 new employees, approved by the company's Compensation Committee in accordance with NASDAQ Listing Rule 5635(c)(4). On September 3, 2024, the employees received options to purchase a total of 137,140 shares of Insmed common stock at an exercise price of $73.31 per share, which was the closing trading price on the Nasdaq Global Select Market on the grant date.
The options have a 10-year term and a four-year vesting schedule. 25% of the shares will vest on the first anniversary of the grant date, followed by 12.5% vesting every six months thereafter until the fourth anniversary, subject to the employee's continued service with Insmed.
Insmed Incorporated (Nasdaq: INSM) ha annunciato l'assegnazione di premi di induzione a 60 nuovi dipendenti, approvata dal Comitato per la Remunerazione dell'azienda in conformità alla Regola di Quotazione NASDAQ 5635(c)(4). Il 3 settembre 2024, i dipendenti hanno ricevuto opzioni per acquistare un totale di 137.140 azioni ordinarie di Insmed a un prezzo di esercizio di $73,31 per azione, che corrispondeva al prezzo di chiusura dell'ultimo trading sul Nasdaq Global Select Market alla data di concessione.
Le opzioni hanno un termine di 10 anni e un programma di maturazione di quattro anni. Il 25% delle azioni maturerà il primo anniversario della data di concessione, seguito dal 12,5% che maturerà ogni sei mesi fino al quarto anniversario, a condizione che il dipendente continui a prestare servizio presso Insmed.
Insmed Incorporated (Nasdaq: INSM) ha anunciado la concesión de premios de inducción a 60 nuevos empleados, aprobada por el Comité de Compensación de la empresa de acuerdo con la Regla de Cotización NASDAQ 5635(c)(4). El 3 de septiembre de 2024, los empleados recibieron opciones para comprar un total de 137,140 acciones ordinarias de Insmed a un precio de ejercicio de $73.31 por acción, que era el precio de cierre en el mercado Nasdaq Global Select en la fecha de concesión.
Las opciones tienen un plazo de 10 años y un cronograma de adquisición de cuatro años. El 25% de las acciones se adquirirán en el primer aniversario de la fecha de concesión, seguido del 12.5% que se adquirirá cada seis meses hasta el cuarto aniversario, sujeto a la continuación del servicio del empleado con Insmed.
Insmed Incorporated (Nasdaq: INSM)는 NASDAQ 상장 규정 5635(c)(4)에 따라 회사 보상 위원회의 승인을 받아 60명의 신규 직원에게 유인 보상을 지급한다고 발표했습니다. 2024년 9월 3일, 직원들은 137,140 주식에 대한 매수 옵션을 받았으며, 행사 가격은 $73.31로, 이는 지급일에 Nasdaq Global Select Market에서의 종가와 일치합니다.
옵션은 10년 만기 및 4년 분할 취득 일정을 가지고 있습니다. 25%의 주식은 수여일의 첫 번째 기념일에 취득되며, 이후 6개월마다 12.5%씩 취득되어 4주년 기념일까지 계속됩니다. 이는 직원이 Insmed에서 계속 근무할 경우에 한합니다.
Insmed Incorporated (Nasdaq: INSM) a annoncé l'attribution de primes d'incitation à 60 nouveaux employés, approuvée par le Comité des Rémunérations de l'entreprise conformément à la Règle d'Inscription NASDAQ 5635(c)(4). Le 3 septembre 2024, les employés ont reçu des options d'achat pour un total de 137,140 actions ordinaires d'Insmed à un prix d'exercice de $73,31 par action, qui était le prix de clôture sur le Nasdaq Global Select Market à la date d'octroi.
Les options ont une durée de 10 ans et un calendrier d'acquisition sur quatre ans. 25 % des actions seront acquises à l'anniversaire de la première année de la date d'octroi, suivi de 12,5 % d'acquisition tous les six mois jusqu'au quatrième anniversaire, sous réserve que l'employé continue de servir chez Insmed.
Die Insmed Incorporated (Nasdaq: INSM) hat die Gewährung von Induktionsprämien an 60 neue Mitarbeiter angekündigt, die vom Vergütungsausschuss des Unternehmens gemäß der NASDAQ-Listing-Regel 5635(c)(4) genehmigt wurden. Am 3. September 2024 erhielten die Mitarbeiter Optionen zum Kauf von insgesamt 137.140 Aktien der Insmed-Stammaktien zu einem Ausübungspreis von $73,31 pro Aktie, was dem Schlusskurs an der Nasdaq Global Select Market am Tag der Gewährung entsprach.
Die Optionen haben eine Laufzeit von 10 Jahren und einen vierjährigen Vesting-Zeitplan. 25 % der Aktien werden am ersten Jahrestag des Gewährungstags fällig, gefolgt von 12,5 %, die alle sechs Monate bis zum vierten Jahrestag fällig werden, vorausgesetzt, der Mitarbeiter bleibt weiterhin bei Insmed beschäftigt.
- Granted stock options to 60 new employees, potentially attracting and retaining talent
- Exercise price of $73.31 per share, aligning with current market value
- 10-year term for options, providing long-term incentive
- Potential dilution of existing shareholders' equity due to new stock options
In connection with the commencement of their employment, the employees received options on September 3, 2024 to purchase an aggregate 137,140 shares of Insmed common stock at an exercise price of
The options have a 10-year term and a four-year vesting schedule, with
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in
Headquartered in Bridgewater,
Contact:
Investors:
Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com
Media:
Mandy Fahey
Vice President, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302238489.html
SOURCE Insmed Incorporated
FAQ
How many new employees received inducement grants from Insmed (INSM) on September 3, 2024?
What is the exercise price of the stock options granted by Insmed (INSM) in the September 2024 inducement awards?
What is the vesting schedule for the stock options granted by Insmed (INSM) in September 2024?
How many shares of Insmed (INSM) common stock were included in the September 2024 inducement grants?
